Setting aside its ban on the sale of oxytocin, the Health Ministry has allowed private retail shops to sell the life-saving hormone from September 1, an official said today.
The ministry in its notification dated April 27 had stated that sale of oxytocin through private retail chemists would be banned from July 1 and that the drug would be sold only in government hospitals and clinics.
Later, it deferred the implementation of the ban till September 1.
"All retail sale shops are permitted to sell oxytocin," the official said.
The government has restricted the manufacture of oxytocin formulations for domestic use to just one public sector company.
State-owned Karnataka Antibiotics Pvt Ltd (KAPL) will be the only company to manufacture and distribute oxytocin in India from September 1.
In a meeting on August 6, the ministry had asked the state governments and Union territories to place purchase orders with KAPL to ensure that there is no shortage of oxytocin injections in government hospitals and clinics.
Oxytocin is a naturally-occurring hormone that causes uterine contractions during labour and helps new mothers lactate.
But its misuse is widespread in the dairy industry where livestock are injected with oxytocin to make them release milk at a time convenient to farmers. The hormone is also used to increase the size of vegetables such as pumpkins, watermelons, brinjals, gourds and cucumbers.
The government has already banned the import of oxytocin and its formulations.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
